Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]

Promising partners for check-point immunotherapy for HCC?

Dr Stephen Chan - The Chinese University of Hong Kong, Hong Kong

Promising partners for check-point immunotherapy for HCC? ( Dr Stephen Chan - The Chinese University of Hong Kong, Hong Kong )

Personalised therapy for lung cancer

Dr Andre Marcio Murad - Clinica Cenantron, Belo Horizonte, Brazil

Personalised therapy for lung cancer ( Dr Andre Marcio Murad - Clinica Cenantron, Belo Horizonte, Brazil )

Interdisciplinarity in the genetics of cancer

Dr. Anton Abílio Santa Rosa - Ministry of Health, Brasil

Interdisciplinarity in the genetics of cancer ( Dr. Anton Abílio Santa Rosa - Ministry of Health, Brasil )

Current and future directions of immunotherapy research

Toh Han Chong - National Cancer Centre, Singapore

Current and future directions of immunotherapy research ( Toh Han Chong - National Cancer Centre, Singapore )

Managing metastatic gastric cancer

Prof Daisuke Sakai - Osaka University, Osaka, Japan

Managing metastatic gastric cancer ( Prof Daisuke Sakai - Osaka University, Osaka, Japan )

Combination immunotherapy for lung cancer

Prof Tony Mok - The Chinese University of Hong Kong, Hong Kong

Combination immunotherapy for lung cancer ( Prof Tony Mok - The Chinese University of Hong Kong, Hong Kong )

Biomarker driven clinical trials

Dr Oleg Gluz - West German Study Group Monchengladbach, Germany

Biomarker driven clinical trials ( Dr Oleg Gluz - West German Study Group Monchengladbach, Germany )

Decoding breast cancer predisposition genes

Dr Fergus Couch - Mayo Clinic, Rochester, USA

Decoding breast cancer predisposition genes ( Dr Fergus Couch - Mayo Clinic, Rochester, USA )

Matched mutations in the progression of metastatic breast cancer

Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA

Matched mutations in the progression of metastatic breast cancer ( Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA )

Whole exome and transcriptome sequencing of resistant ER positive metastatic...

Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA

Whole exome and transcriptome sequencing of resistant ER positive metastatic breast cancer ( Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA )

Pacritinib versus best available therapy for low platelet Myelofibrosis

Dr John Mascarenhas - Mount Sinai School of Medicine New York, USA

Pacritinib versus best available therapy for low platelet Myelofibrosis ( Dr John Mascarenhas - Mount Sinai School of Medicine New York, USA )

ASH 2016 highlights: breaking new ground in haematology

Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy

ASH 2016 highlights: breaking new ground in haematology ( Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy )

More from ecancer